The stimulation of neoangiogenesis in the ischemic human heart by the growth factor FGF: First clinical results

Journal of Cardiovascular Surgery

Volumn 39, Issue 6, 1998, Pages 783-789

  Schumacher, B ^a,c   Stegmann, Th ^b   Pecher, P ^a  

^a UNIVERSITY OF ULM   (Germany)

^b KLINIKUM FULDA   (Germany)

^c UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

Fibroblast Growth Factor; Myocardial ischemia; Neovascularization, physiologic drug therapy

Indexed keywords

FIBROBLAST GROWTH FACTOR;

ADULT; ANGIOGENESIS; ANGIOGRAPHY; ARTICLE; CLINICAL ARTICLE; CLINICAL RESEARCH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; DOUBLE BLIND PROCEDURE; ESCHERICHIA COLI; FEMALE; FOLLOW UP; HEART MUSCLE ISCHEMIA; HUMAN; ISCHEMIC HEART DISEASE; MALE; RANDOMIZED CONTROLLED TRIAL; VASCULARIZATION;

ANGIOGRAPHY, DIGITAL SUBTRACTION; ANIMALS; CORONARY ANGIOGRAPHY; CORONARY ARTERY BYPASS; CORONARY CIRCULATION; DOUBLE-BLIND METHOD; FIBROBLAST GROWTH FACTORS; FOLLOW-UP STUDIES; HUMANS; INJECTIONS; INTRAOPERATIVE PERIOD; MIDDLE AGED; MYOCARDIAL ISCHEMIA; MYOCARDIUM; NEOVASCULARIZATION, PHYSIOLOGIC; RABBITS; RATS; RECOMBINANT PROTEINS;

EID: 0032465114     PISSN: 00219509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Lamm G. The CVD Programme of WHO in Europe, Public Health in Europe. WHO/EURO 1981;15:16.
2. Favaloro RG. Saphenous vein autograft replacement of severe segmental coronary artery occlusion. Ann Thorac Surg 1968;5:334.
3. Kolossov VJ. Mammary artery-coronary anastomosis as a method of treatment for angina pectoris. J Thorac Cardiovasc Surg 1967;54:535.
4. Vineberg AM. Evidence that revascularisation by ventricular internal mammary artery implants increases longevity. J Thorac Cardiovasc Surg 1975;70:3.
5. Vineberg AM. Development of anastomoses between the coronary vessels and a transplanted internal mammary artery. Can Med Assoc J 1946;55:117-19.
6. Beck CS, Tichy VL, Moritz AR. Production of a collateral circulation to the heart. Proc Soc Exp Biol Med 1935;32:759-63.
7. Glenn WL. Some reflection on the coronary bypass operation. Circulation 1972;14:869.
8. Grüntzig A, Senning A, Siegenthaler WE. Nonoperative dilatation of coronary artery stenosis. Percutaneous transluminal angioplasty. N Engl J Med 1979;301:61-8.
9. Baffour R, Berman J, Garb JL, Rhee SW, Kaufman J, Friedmann P. Enhanced angiogenesis and growth of collaterals by in vivo - administration of recombinant basic fibroblast growth factor in a rabbit model of acute lower limb ischemia: dose-response effect of basic fibroblast growth factor. J Vasc Surg 1992;16:181-91.
10. Fasol R, Schumacher B, Schlaudraf K, Hauenstein KH, Seitelberger R. Experimental use of a modified fibrin-glue to induce site-directed angiogenesis from the aorta to the heart. J Thorac Cardiovasc Surg 1994;107:1432-9.
11. Schlaudraff K, Schumacher B, Seitelberger R, v. Specht B-U, Schlosser V, Fasol R. An Experimental Study of in situ and in vivo Growth of new Arteries by the Angiogenetic Growth-Factor HBGF-I. Thorac Cardiovasc Surg 1992;40:136.
12. Schlaudraff K, Schumacher B, Seitelberger R, v. Specht B-U, Schlosser V, Fasol R. Can you grow New Arteries for CV-Surgeons? J Cardiovasc Surg 1992;33:47.
13. Schlaudraff K, Schumacher B, v. Specht B-U, Seitelberger R, Schlosser V, Fasol R. Growth of new coronary vascular structures by angiogenetic growth factors Eur J Cardio-thorac Surg 1993;7: 637-44.
14. Thompson JA, Anderson KD, Di Pietro JM, Maciag T. Site-directed neovessel formation in vivo. Science 1988;241:1349-52.
15. Vanagisawa-Miwa A, Uchida Y, Makamura F et al. Salvage of infarcted myocardium by angiogenic action of basic fibroblast growth factor. Science 1992;257:1401-2.
16. Dionne CA, Crumley G, Bellot F, Kaplow JM, Searfoss G, Ruta M et al. Cloning and expression of two distinct high-affinity receptors cross-reacting with acidic and basic fibroblast growth factors. EMBO J 1990;9:2685-92.
17. Folkman J, Klagsbrun M. Angiogenetic factors. Science 1987;235:442-7.
18. Friesel R, Burgess WH, Mehrman T, Maciag T. The characterization of the receptor for endothelial cell growth factor by covalent ligand attachment. J Biol Chem 1986;261:7581-4.
19. James R, Bradshaw RA. Polypeptide growth factors Ann Rev Biochem 1984;53:259-92.
20. Maciag T. Angiogenesis. Prog Haemost Thromb 1984;7:107-82.
21. Thomas KA. Fibroblast growth factors. FASEB J 1987;1:434-40.
22. Albes JM, Kletzner T, Kotzerke J, Thiedemann KU, Schäfers HJ, Borst HG. Improvement of tracheal autograft revascularisation by means of fibroblast growth factor. Ann Thorac Surg 1994;57: 444-9.
23. Schumacher B, v. Specht B-U, Haberstroh J, Pecher P. The stimulation of neoangiogenesis in the ischemic heart by the human growth factor FGF J Cardiovasc Surg 199839:445-53.
24. Gospodarowicz D, Cheng J, Kui GM. Isolation of brain fibroblast growth factor by heparine- sepharose affinity chromatography: Identity with pituitary fibroblast growth factor. Proc Natl Acad Sci USA 1984;81:6963-7.
25. Forough R, Engleka K, Thompson JA, Jackson A, Imamura T, Maciag T. Differential expression in E. coli of the alpha and beta forms of heparin-binding-fibroblast growth factor I: Potential role of RNA secondary structure. Biochem Biophys Acta 1991;1090:293-8.
26. Lämmli UK. Cleavage of structure proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-5.
27. Wilson RF, Johnson MR, Marcus ML, Aylward PE, Skorton DJ, Collins S, White CW. The effect of coronary angioplasty on coronary flow reserve. Circulation 1988;77:873-85.
28. Savchenko AP, Pomerantsev EV, Abugov SA, Blank ML. A Videodensometric analysis of the characteristics of coronary blood flow using computed digital angiography in patients with ischemic heart disease. Biulleten Vsesoiuznogo Kardiologicheskogo Nauchnogo Tsentra Amn SSSR 1988;11:96-102.
29. Pijls NH, Bos HS, Uijen GJ, Van der Werf T. Is nonionic isotonic iohexol the contrast agent of choice for quantitative myocardial videodensitomerty? Int J Cardiac Imaging 1988;3:117-26.
30. Chang BL, Drury, JK, Meerbaum S, Fishbein MC, Whiting JS, Corday E. Enhanced myocardial washout and retrograde blood delivery with synchronized retroperfusion during acute myocardial ischemia. J Am Coll Cardiol 1987;9:1091-8.
31. Nishimura RA, Rogers PJ, Holmes DR JR, Gehring DG, Bove AA. Assessment of myocardial perfusion by videodensitometry in the canine model. J Am Coll Cardiol 1987;9:891-7.
32. Schlaudraff K, v. Specht B-U, Kolvenbach H, Stegmann Th, Schumacher B: Induktion neuer funktioneller Blutgefasse beim Menschen. Langenbeck Arch Chir Chirurgisches Forum 1994:164-72.
33. Paterno GD, Gillespie LL, Dixon MS, Slack JM, Head JK. Mesoderm-inducing properties of INT-2 and k FGF: Two oncogene encoded growth factors related to FGF. Development 1989;106:79-83.
34. Lipton SA, Wagner JA, Madison RD, D'Amore PA. Acidic fibroblast growth factor enhances regeneration of processes by post-natal mammalian retinal ganglion cells in culture. Proc Natl Acad Sci USA 1988;85:2388-92.
35. Lathrop B, Olson E, Glaser L. Control by fibroblast growth factor of differentiation in the BC 3H1 muscle cell line. J Cell Biol 1985;100:1540-7.
36. Lobb RR; Alderman EM, Fett JW. Induction of angiogenesis by bovine brain derived class I heparin-binding growth factor. Biochemistry 1985;24:4969-73.
37. Crumley G, Bellot F, Kaplov JM, Schlessinger J, Jaye M, Dionne CA. High-affinity binding and activation of truncated FGF receptor by both a-FGF and b-FGF. Oncogene 1991;6:2255-62.
38. Folkman J. Angiogenesis and its inhibitors. In: Hellman S, Rosenberg S, editors. De Vita. Important advances in oncology. Philadelphia: JB Lippincott, 1985:42-62.
39. Montesano R, Vasalli JD, Baird RD, Guillemin R, Orci L. Basic fibroblast growth factor induces angiogenesis in vitro. Proc Natl Acad Sci USA 1986;83:7297-301.
40. Thompson JA, Haudenschild CC, Anderson KD, Di Pietro JM, Maciag T. Heparin-binding growth factor I induces the formation of organoid neovascular structures in vivo. Proc Natl Acad Sci USA 1989;86:7928-32.
41. Burgess WH, Mehlman T, Friesel R, Johnson WV, Maciag T. Multiple forms of endothelial cell growth factor. Rapid isolation and biological and chemical characterization. J Biol Chem 1985; 260:11389-92.
42. Mehlman T, Burgess WH. Detection and characterization of heparin- binding proteins with a gel overlay procedure. An Biochem 1990;188:159-63.
43. Thomas KA. Transforming potential of fibroblast growth factor. Trends Biochem Sci 1988;13:327-8.
44. Jaye M, Lyall RM, Mudd R, Schlessinger J, Sarver N. Expression of acidic fibroblast growth factor cDNA confers growth advantage and tumorigenesis to Swiss 3T3 cells. EMBO J 1988;7:963-9.
45. Schumacher B, Pecher P, v Specht B-U, Stegmann Th. Induction of neoangiogenesis in ischemic myocardium by human growth factors: First clinical results of a new treatment of coronary heart disease. Circulation 1997, in press.
46. Holzner JH. Arbeitsbuch Pathologie. Allgemeine Pathologie Band I. Urb Schwarzenb 1989;1:112-3.
47. Ware A, Simons M. Angiogenesis in ischemic heart disease. Nat Med 1997;3:158-64.